Moosavi R, Bremner F, Acheson J
University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy.
Open Ophthalmol J. 2014 Oct 3;8:73-4. doi: 10.2174/1874364101408010073. eCollection 2014.
We report adherence to United Kingdom national guidelines on surveillance for Fingolimod associated macular oedema (FAME) and the impact on clinical services at our unit. We conducted a 9-month study, measuring referral interval, visual function and performing OCT scans for all patients referred for FAME surveillance. 38 patients in total were seen, representing 9% of all new ophthalmic referrals during the study period. 26% were seen between 2 and 4 months after starting Fingolimod treatment, 74% between 3 and 4 months after starting Fingolimod treatment. The impact on clinical services is discussed.
我们报告了对英国关于芬戈莫德相关黄斑水肿（FAME）监测的国家指南的遵循情况以及对我们科室临床服务的影响。我们进行了一项为期9个月的研究，测量所有因FAME监测而转诊患者的转诊间隔、视觉功能并进行光学相干断层扫描（OCT）。总共诊治了38名患者，占研究期间所有眼科新转诊患者的9%。26%的患者在开始使用芬戈莫德治疗后的2至4个月内就诊，74%的患者在开始使用芬戈莫德治疗后的3至4个月内就诊。文中讨论了对临床服务的影响。
